多序列MRI与临床变量预测局部晚期宫颈鳞癌放疗反应
本研究回顾性纳入248例经病理证实的局部晚期宫颈鳞癌患者,随机分为训练集173例与验证集75例。基于治疗前T1WI、T2WI、T2-SPAIR和DWI提取深度学习特征,并与临床变量融合,构建四种机器学习模型预测外照射后肿瘤缩小率。融合模型AUC为0.824-0.863,优于单一序列模型,其中RSF模型准确度最高。
要点
- 多序列MRI影像组学联合临床变量的融合模型预测放疗后肿瘤缩小率,优于任何单一MRI序列模型。
- RSF融合模型表现最佳,准确度0.920、敏感度0.937、特异度0.833、AUC 0.863。
- 治疗前MRI多序列深度学习特征可用于早期识别放疗反应差的高危患者,辅助个体化治疗决策。
核心结论
- 深度学习影像组学-临床融合模型对局部晚期宫颈鳞癌外照射后肿瘤缩小率具有较好预测能力。
- RSF融合模型性能最佳,准确度0.920、敏感度0.937、特异度0.833、AUC 0.863。
- 基于治疗前多序列MRI的模型有助于放疗前早期识别高危患者,支持个体化治疗计划制定。
研究设计与样本
- 回顾性研究,纳入248例经组织病理证实的局部晚期宫颈鳞癌患者,时间为2020年4月至2025年4月。
- 队列随机分为训练集173例和验证集75例进行内部测试。
- 在治疗前T1WI、T2WI、T2-SPAIR和DWI四个MRI序列上由深度学习模型提取深度特征,并与临床变量融合。
- 训练并比较CWGBS、XGBoost、GBST和RSF四种模型,评价指标包括AUC、准确度、敏感度和特异度。
关键影像表现/征象
- 融合模型AUC范围为0.824-0.863,高于仅基于DWI(AUC 0.711-0.754)、T1WI(AUC 0.681-0.737)、T2WI(AUC 0.694-0.825)和T2-SPAIR(AUC 0.714-0.827)的模型。
- 多序列MRI影像组学特征联合临床变量对放疗后肿瘤缩小率的预测效能优于任何单一序列模型。
诊断标准与关键数值
- RSF融合模型:准确度0.920、敏感度0.937、特异度0.833、AUC 0.863,为四种融合模型中最高。
- 四种融合模型AUC范围为0.824-0.863。
- 单一序列模型AUC范围:DWI为0.711-0.754,T1WI为0.681-0.737,T2WI为0.694-0.825,T2-SPAIR为0.714-0.827。
临床应用与阅片要点
- 治疗前多序列MRI可提供预测放疗反应的高价值信息,阅片时应注意T1WI、T2WI、T2-SPAIR及DWI序列的完整性。
- 放射科报告可提示临床关注多序列MRI影像组学风险分层,辅助筛选放疗反应可能不佳的高危患者。
局限性
- 本研究为单中心回顾性设计,验证方式仅为内部随机验证,缺乏外部独立验证集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Locally advanced cervical cancer (LACC) remains a major cause of cancer-related mortality among women. We developed and tested a machine learning model integrating radiomic and clinical features to predict tumor shrinkage rate (TSR) after external beam radiotherapy (EBRT).
MATERIALS AND METHODS: This study retrospectively enrolled 248 patients with histopathologically confirmed locally advanced cervical squamous cell carcinoma from April 2020 to April 2025. The cohort was split randomly into a training set (n = 173) and a validation set (n = 75) for internal testing. A deep learning model extracted deep features from T1-weighted, T2-weighted, T2-SPAIR, and diffusion-weighted imaging (DWI) pretreatment Magnetic resonance imaging (MRI) sequences. Fusion combined these radiomic features with clinical variables. Conditional weighted gradient boosting survival (CWGBS), eXtreme Gradient Boosting (XGBoost), gradient boosting survival tree (GBST), and random survival forest (RSF) models were trained on the fused dataset. Model performance metrics comprised area under the receiver operating characteristic curve Area Under the Curve (AUC), accuracy, sensitivity, and specificity.
RESULTS: The machine-learning radiomics-clinical fusion models demonstrated robust performance in predicting TSR after EBRT. The AUCs of the four fusion models ranged from 0.824 to 0.863, outperforming models based solely on DWI (AUC 0.711-0.754), T1WI (AUC 0.681-0.737), T2WI (AUC 0.694-0.825), or T2-SPAIR (AUC 0.714-0.827). Among them, the RSF model achieved the highest accuracy (0.920), sensitivity (0.937), specificity (0.833), and AUC (0.863).
CONCLUSION: A deep-learning radiomics-clinical model demonstrated robust capability for predicting TSR after EBRT in LACC. Early identification of high-risk patients supports individualized treatment planning.
引用
- Zhuo, Wang, Li, et al. Predicting Response to Radiotherapy in Locally Advanced Cervical Squamous Cell Carcinoma Based on Multisequence MRI and Clinical Variables. Acad Radiol. 2026. PMID: 42538219. doi:10.1016/j.acra.2026.07.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。